6th International Conference on

VaccinesResearch & Development

Register

Speakers

John Mascola
John Mascola
Director, Vaccine Research Center, NIH
Kathleen Maletic Neuzil
Kathleen Maletic Neuzil
Director, Center for Vaccine Development and Global Health, UMSOM
Andrea Carfi
Andrea Carfi
VP & Head of Research, Infectious Disease, Moderna Inc.
Dan H. Barouch
Dan H. Barouch
Director, Center for Virology and Vaccine Research, BIDMC
Julie A. Ake
Julie A. Ake
Director, US Military HIV Research Program
David B. Weiner
David B. Weiner
Director
The Wistar Institute
Jacqueline Miller
Jacqueline Miller
Sr. VP & Therapeutic Area Head, Infectious Disease, Moderna Inc
Derek T. O’ Hagan
Derek T. O' Hagan
Senior Advisor Vaccines R&D
GSK

A Glimpse of Our Journey

International Conference on Vaccines Research and Development is a part of successful series of conference started from 2015 and held annually since then. The main objective of this conference is to bring eminent scientists together to share their ideas and provide a critical review of present state of the field. It is designed in such a way that it provides an opportunity to meet up with people from both industry and academia and establish a scientific network between them.

A Glimpse of Our Journey

International Conference on Vaccines Research and Development is a part of successful series of conference started from 2015 and held annually since then. The main objective of this conference is to bring eminent scientists together to share their ideas and provide a critical review of present state of the field. It is designed in such a way that it provides an opportunity to meet up with people from both industry and academia and establish a scientific network between them.

A Glimpse of Our Journey

International Conference on Vaccines Research and Development is a part of successful series of conference started from 2015 and held annually since then. The main objective of this conference is to bring eminent scientists together to share their ideas and provide a critical review of present state of the field. It is designed in such a way that it provides an opportunity to meet up with people from both industry and academia and establish a scientific network between them.

Why join Vaccines R&D 2021?

Collaborative Meetings

Opportunity for one-on-one collaboration meeting to facilitate more interaction with potential clients for corporate partnering, investment pitch, or any other collaboration.

01

Get Hired

The leading industrialists and academicians can post about any open positions in their organization or lab at Vaccines R&D 2021 platform.

02

Networking Opportunities

The networking breaks during the meeting has led to many collaborations and new job opportunities for the attendees.

03

Submit your abstract

What Speakers Say

I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.

Rino Rappuoli, Chief Scientist & Head of External Research and Development, GSK Vaccines

What Speakers Say

I truly enjoyed being part of the conference, which was very interesting and divers. I must also say that it was very well run and a pleasure to be part of it.

Nathalie Garçon, Chief Executive and Scientific Officer, IRT BIOASTER

What Speakers Say

It was really a great meeting this year, with an impressive roster of speakers the day I attended.

Jay A. Berzofsky, Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute

What Speakers Say

Congratulations. You have really made progress, and the meeting is getting better each time

Stephen L. Hoffman, Chief Executive and Scientific Officer, Sanaria Inc.

What Speakers Say

Thank you, I learned much at this meeting and made many new contacts

Michael G. Hanna, Founder and Chairman Emeritus, Vaccinogen Inc.

What Speakers Say

The meeting is getting better every year. Great work in organizing the speaker line

Farshad Guirakhoo, Chief Scientific Officer, GeoVax, Inc.

What Speakers Say

The first one was pretty bad but they have gotten progressively better. I thought Vaccine R&D2018 in Baltimore was well worth attending

Andrew Lees, Scientific Director, Owner, Fina BioSolutions LLC

/

Early Bird Registration

June 18, 2021 Fast & Easy Online Registration

Sponsors & Exhibitors

2014

Year of Foundation

765

Speakers

2500+

Attendees

150

Happy Clients